Cimzia 200 mg solution for injection in pre-filled syringe
Condition : New
0
From UAE
To Germany
in 5-10 days
Description
How It Works
Cimzia (Certolizumab pegol) is a medication used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, and plaque psoriasis. It works by targeting and neutralizing tumor necrosis factor-alpha (TNF-?), a pro-inflammatory cytokine that plays a key role in the pathogenesis of these diseases. By blocking TNF-?, Cimzia helps to reduce inflammation and relieve symptoms associated with autoimmune conditions.List of Side Effects
- Injection site reactions (pain, redness, swelling)
- Headache
- Upper respiratory tract infections
- Hypertension (high blood pressure)
- Increased risk of infections
List of Indications
- Rheumatoid arthritis
- Psoriatic arthritis
- Ankylosing spondylitis
- Crohn’s disease
- Plaque psoriasis
List of Contraindications
- Hypersensitivity to certolizumab pegol or any of the excipients
- Active infections
- History of tuberculosis
- Patients with demyelinating disorders
- Patients with congestive heart failure
Price in Different Countries
Country | Price (USD) | Reference Website |
---|---|---|
United States | $3,000 | Drugs.com |
United Kingdom | ?2,500 | NHS UK |
Canada | $3,500 CAD | CanadaDrugs.com |
Australia | $4,000 AUD | Chemist Warehouse |
India | ?250,000 INR | Medlife |
Top 5 Global Brands
- Cimzia (Certolizumab pegol) – UCB Pharma
- Humira (Adalimumab) – AbbVie
- Enbrel (Etanercept) – Pfizer
- Remicade (Infliximab) – Janssen Biotech
- Sympy (Adalimumab) – Syneos Health